267 related articles for article (PubMed ID: 33051464)
1. NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer's disease.
He XF; Xu JH; Li G; Li MY; Li LL; Pei Z; Zhang LY; Hu XQ
Cell Death Dis; 2020 Oct; 11(10):849. PubMed ID: 33051464
[TBL] [Abstract][Full Text] [Related]
2. Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome.
Tejera D; Mercan D; Sanchez-Caro JM; Hanan M; Greenberg D; Soreq H; Latz E; Golenbock D; Heneka MT
EMBO J; 2019 Sep; 38(17):e101064. PubMed ID: 31359456
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
4. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice.
Dempsey C; Rubio Araiz A; Bryson KJ; Finucane O; Larkin C; Mills EL; Robertson AAB; Cooper MA; O'Neill LAJ; Lynch MA
Brain Behav Immun; 2017 Mar; 61():306-316. PubMed ID: 28003153
[TBL] [Abstract][Full Text] [Related]
6. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.
Van Zeller M; Dias D; Sebastião AM; Valente CA
J Alzheimers Dis; 2021; 83(3):939-961. PubMed ID: 34366341
[TBL] [Abstract][Full Text] [Related]
8. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway.
Jung ES; Suh K; Han J; Kim H; Kang HS; Choi WS; Mook-Jung I
Aging Cell; 2022 May; 21(5):e13623. PubMed ID: 35474599
[TBL] [Abstract][Full Text] [Related]
10. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
[TBL] [Abstract][Full Text] [Related]
11. Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice.
Kim N; Do J; Ju IG; Jeon SH; Lee JK; Oh MS
Neurotherapeutics; 2020 Jan; 17(1):189-199. PubMed ID: 31741224
[TBL] [Abstract][Full Text] [Related]
12. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ
Zhang Y; Zhao Y; Zhang J; Gao Y; Li S; Chang C; Yu D; Yang G
Neurosci Lett; 2021 Nov; 764():136206. PubMed ID: 34478813
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice.
Heneka MT; Kummer MP; Stutz A; Delekate A; Schwartz S; Vieira-Saecker A; Griep A; Axt D; Remus A; Tzeng TC; Gelpi E; Halle A; Korte M; Latz E; Golenbock DT
Nature; 2013 Jan; 493(7434):674-8. PubMed ID: 23254930
[TBL] [Abstract][Full Text] [Related]
15. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
17. Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
Li Y; Chen X; Zhou M; Feng S; Peng X; Wang Y
J Alzheimers Dis; 2024; 97(1):75-88. PubMed ID: 38043010
[TBL] [Abstract][Full Text] [Related]
18. CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells.
Yan S; Xuan Z; Yang M; Wang C; Tao T; Wang Q; Cui W
Int Immunopharmacol; 2020 Apr; 81():106263. PubMed ID: 32028243
[TBL] [Abstract][Full Text] [Related]
19. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway.
Liu P; Zhou Y; Shi J; Wang F; Yang X; Zheng X; Wang Y; He Y; Xie X; Pang X
Phytomedicine; 2023 Jul; 115():154801. PubMed ID: 37086707
[TBL] [Abstract][Full Text] [Related]
20. PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer's disease.
Wang BR; Shi JQ; Ge NN; Ou Z; Tian YY; Jiang T; Zhou JS; Xu J; Zhang YD
J Neuroinflammation; 2018 May; 15(1):132. PubMed ID: 29720213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
